Literature DB >> 16265701

Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed?

José Alvarez-Nemegyei1, Martha Medina-Escobedo, Salha Villanueva-Jorge, Janitzia Vazquez-Mellado.   

Abstract

OBJECTIVE: To assess the prevalence and risk factors for urolithiasis in primary gout.
METHODS: One hundred forty patients with primary gout were studied. Urolithiasis was defined as a history of urolithiasis, or nephrolithiasis detected via ultrasonography in patients with no previous record of urolithiasis. Patient age, duration of gout, presence of tophi, obesity, alcoholism, high blood pressure, diabetes, hyperlipidemia, family history of urolithiasis, daily urine output, uricemia, urine pH, FeNa, FeUrate, urine pH/FeUrate index, and daily urine excretion of urate, sodium, calcium and potassium were compared between lithiasic and non-lithiasic subjects.
RESULTS: Fifty-five (39%; 95% CI 31-47) patients had urolithiasis, of which 37 (26%) were diagnosed by clinical history and 18 (13%) by ultrasonography. Patients with a silent kidney stone diagnosed by ultrasound tended to have shorter evolution of gout. Aside from urinary H+ ion concentration (lithiasic subjects 5.17 +/- 3.9 microM/l; non-lithiasic subjects 3.80 +/- 3.01 microM/l; p = 0.02), no difference was found between lithiasic and non-lithiasic subjects for the other variables studied.
CONCLUSION: Ultrasonography increased the probability of diagnosing urolithiasis by 50%, meaning the prevalence of urolithiasis in gout is likely higher than previously reported. A higher urinary H+ ion concentration was the only variable associated with urolithiasis. Due to advances in diagnosis of gout and urolithiasis, as well as biochemical assays, the prevalence and risk factors for urolithiasis in gout require reassessment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265701

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Update on the pathophysiology and management of uric acid renal stones.

Authors:  Jon-Emile S Kenny; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

2.  High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study.

Authors:  Stephen A Wright; Emilio Filippucci; Claire McVeigh; Arthur Grey; Maura McCarron; Walter Grassi; Gary D Wright; Allister J Taggart
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

3.  Epidemiology of urolithiasis: an update.

Authors:  Alberto Trinchieri
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

4.  Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients.

Authors:  Ozren Polasek; Grgo Gunjaca; Ivana Kolcić; Lina Zgaga; Snjezana Dzijan; Robert Smolić; Martina Smolić; Jasminka Milas-Ahić; Vatroslav Serić; Josip Galić; Sandra Tucak-Zorić; Antun Tucak; Igor Rudan; Gordan Lauc
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

5.  The Occurrence of Nephrolithiasis in Gout Patients: A Longitudinal Follow-Up Study Using a National Health Screening Cohort.

Authors:  So Young Kim; Dae Myoung Yoo; Ji Hee Kim; Mi Jung Kwon; Joo-Hee Kim; Jung Woo Lee; Woo Jin Bang; Hyo Geun Choi
Journal:  Life (Basel)       Date:  2022-04-28

6.  Comparison potassium sodium hydrogen citrate with sodium bicarbonate in urine alkalization: a prospective crossover-controlled trial.

Authors:  Wen Xue; Jiafen Cheng; Jing Zhao; Ling Wang; Ai Peng; Xinying Liu
Journal:  Int Urol Nephrol       Date:  2022-10-19       Impact factor: 2.266

Review 7.  Treatment of patients with uric acid stones.

Authors:  Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

Review 8.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

9.  Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis.

Authors:  Silvia Tore; Stefania Casula; Giuseppina Casu; Maria Pina Concas; Paola Pistidda; Ivana Persico; Alessandro Sassu; Giovanni Battista Maestrale; Caterina Mele; Maria Rosa Caruso; Bibiana Bonerba; Paolo Usai; Ivo Deiana; Timothy Thornton; Mario Pirastu; Paola Forabosco
Journal:  PLoS Genet       Date:  2011-01-20       Impact factor: 5.917

Review 10.  Uric acid nephrolithiasis.

Authors:  Scott E Liebman; Jeremy G Taylor; David A Bushinsky
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.